Ticker >

Fischer Medical share price

Fischer Medical Ventures Ltd.

BSE: 524743 SECTOR: Chemicals  9866   13   0

649.95
+7.55 (1.18%)
BSE: 01 Nov 07:00 PM

Price Summary

Today's High

₹ 660

Today's Low

₹ 612

52 Week High

₹ 792.65

52 Week Low

₹ 76.66

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

3477.23 Cr.

Enterprise Value

3477.23 Cr.

No. of Shares

5.35 Cr.

P/E

2402.77

P/B

43.66

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  14.89

CASH

0 Cr.

DEBT

0 Cr.

Promoter Holding

74.91 %

EPS (TTM)

₹  0.27

Sales Growth

6322.4%

ROE

1.03 %

ROCE

1.39%

Profit Growth

1203.56 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year6322.4%
3 Year311.86%
5 Year∞%

Profit Growth

1 Year1203.56%
3 Year42.03%
5 Year145.3%

ROE%

1 Year1.03%
3 Year0.34%
5 Year0.21%

ROCE %

1 Year1.39%
3 Year-29.16%
5 Year-24.79%

Debt/Equity

0

Price to Cash Flow

43629.02

Interest Cover Ratio

35.0949

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 74.91 0.00
Jun 2024 74.91 0.00
Mar 2024 0.00 0.00
Dec 2023 0.00 0.00
Sep 2023 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 311.863246466842% for the Past 3 years.
  • The company has significantly decreased its debt by 0.5717 Cr.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of -1.33189999999999 days.
  • Company has a healthy liquidity position with current ratio of 4.1515.
  • The company has a high promoter holding of 74.91%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.42759158910982.
  • Promoter stake has increased from 0% to 74.91% in the last 1 quarter.

 Limitations

  • Company has a poor ROE of 0.3419% over the past 3 years.
  • Company has a poor ROCE of -29.1602977755308% over the past 3 years
  • Company has high debtor days of 203.767.
  • The company has a low EBITDA margin of -3.28261476889614% over the past 5 years.
  • The company is trading at a high PE of 2402.77.
  • The company is trading at a high EV/EBITDA of 2048.5226.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
Net Sales 0 0.19 0 11.34 0
Total Expenditure 0.1 0.05 0.15 11.44 0.11
Operating Profit -0.1 0.14 -0.15 -0.1 -0.11
Other Income 0 0.01 0.01 0.72 1.12
Interest 0.02 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.11 0.16 -0.13 0.63 1.01
Tax 0.11 0.01 0 0.03 0.17
Profit After Tax -0.22 0.14 -0.13 0.6 0.84
Adjusted EPS (Rs) -12.67 0.58 -0.53 0.11 0.16

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0.18 0.17 0 0.18 11.53
Total Expenditure 0.21 0.18 0.19 0.16 11.72
Operating Profit -0.02 -0.02 -0.19 0.02 -0.2
Other Income 0 0 0 0 0.75
Interest 0.02 0.02 0.01 0.02 0.02
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.04 -0.04 -0.2 0 0.54
Tax 0 -0.18 0.04 0.04 0.14
Net Profit -0.04 0.14 -0.23 -0.04 0.4
Adjusted EPS (Rs.) -2.39 8.17 -13.52 -2.12 0.08

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.17 0.17 0.17 0.17 53.5
Total Reserves -0.31 -0.17 -0.4 -0.44 26.18
Borrowings 0.22 0.23 0 0 0
Other N/C liabilities 0 -0.18 -0.14 -0.11 0
Current liabilities 0.06 0.02 0.42 0.62 12.18
Total Liabilities 0.14 0.08 0.05 0.25 91.86
Assets
Net Block 0 0 0 0 0.01
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 41.28
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 0.14 0.08 0.05 0.25 50.57
Total Assets 0.14 0.08 0.05 0.25 91.86
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -0.04 -0.04 -0.2 0 0.54
Adjustment 0.02 0.02 0.01 0.02 0.02
Changes in Assets & Liabilities 0.05 -0.04 0.01 -0.16 -0.43
Tax Paid -0.01 0 0 0 -0.05
Operating Cash Flow 0.01 -0.06 -0.18 -0.15 0.08
Investing Cash Flow 0 0 0 0 -37.78
Financing Cash Flow 0 0 0.15 0.17 37.67
Net Cash Flow 0.01 -0.06 -0.03 0.02 -0.03

Corporate Actions

Investors Details

PARTICULARS Jun 2018% Sep 2018% Dec 2018% Jun 2024% Sep 2024%
promoters 7.07 7.07 0.01 74.91 74.91
shankar varadharajan - - - 12.90 12.90
time medical internationa... - - - - 62.01
time medical internationa... - - - 62.01 -
sankaranarayanan g m 7.07 7.07 0.01 - -
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 100.00 100.00 100.00 25.09 25.09
blue lotus capital multi ... - - 1.68 1.68 1.68
hithesh natwarlal kawa - - - - 1.68
india emerging giants fun... - - - - 2.24
jitendra rasiklal sanghav... - - 1.26 1.26 1.26
kaushik hasmukhlal gandhi... - - - 1.59 1.55
natwarlal keshavjibhai ka... - - - 1.68 1.68
nimesh sahadeo singh - - 1.64 1.64 1.45
roopal hitesh kawa - - - - 3.36
vikasa india eif i fund - - 2.83 2.83 2.83
hitesh natwarlal kawa . - - 1.68 1.68 -
india emerging giants fun... - - 2.24 2.24 -
roopal hitesh kawa . - - 3.36 3.36 -
kaushik hasmukhlal gandhi... - - 1.59 - -
natwarlal keshavjibhai ka... - - 1.68 - -
shankar varadharajan [the... - - 12.90 - -
time medical internationa... - - 62.01 - -
amarshi shambhulal mehta 2.00 2.00 - - -
amiben jitendrakumar suth... 9.00 9.00 - - -
archana h singh 3.00 3.00 - - -
atul himatlal dani 4.00 4.00 - - -
bhavik joshi 7.32 7.32 - - -
chirag jitendra shah 8.00 8.00 - - -
dev mehta 2.00 2.00 - - -
dimpalben patel 4.00 4.00 - - -
dimple h mehta 2.00 2.00 - - -
gaurav gurcharan singh ga... 3.00 3.00 - - -
hariom krishna singh 3.00 3.00 - - -
harshadkumar amarshibhai ... 2.00 2.00 - - -
hemali raj mehta 7.60 7.60 - - -
jay mahendrakumar patel 4.00 4.00 - - -
kalpana rohitkumar shah 3.00 3.00 - - -
krunal rohitkumar shah 3.00 3.00 - - -
mitesh manilalbhai thacke... 2.00 2.00 - - -
prachi smit dani 2.60 2.60 - - -
prakash mohanlal parekh h... 2.00 2.00 - - -
pranita prakash dhuri 4.00 4.00 - - -
pravina atul dani 2.60 2.60 - - -
shivani jay patel 4.00 4.00 - - -
soham shashikant panchal 4.00 4.00 - - -
thacker manilal bhavanji 2.00 2.00 - - -
unnati krunal shah 3.00 3.00 - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Fischer Medical Ventures informs about compliance certificate15 Oct 2024, 4:42PM Fischer Medical Ventures informs about press release26 Aug 2024, 12:34PM Fischer Medical Ventures informs about statement of deviation or variation 16 Aug 2024, 9:40AM Fischer Medical - Quaterly Results14 Aug 2024, 7:20PM Fischer Medical - Quaterly Results14 Aug 2024, 7:20PM Fischer Medical Ventures informs about press release24 Jul 2024, 12:14PM Fischer Medical Ventures, Malaysia’s HDT collaborate to launch DoctorOnCall platform worldwide24 Jul 2024, 10:39AM Fischer Medical Ventures informs about loss of share certificate20 Jul 2024, 2:05PM Fischer Medical Ventures collaborates with Nanyang Biologics16 Jul 2024, 11:58AM Fischer Medical Ventures signs MoU with Tech Avant-Garde9 Jul 2024, 12:50PM Fischer Medical Ventures informs about closure of trading window27 Jun 2024, 2:27PM Fischer Medical Ventures informs about press release25 Jun 2024, 12:06PM Fischer Medical Ventures enters into partnership with BluSim Tech10 Jun 2024, 5:37PM Fischer Medical Ventures informs about statement of deviation or variation 1 Jun 2024, 10:19AM Fischer Medical - Quaterly Results30 May 2024, 8:20PM Fischer Medical - Quaterly Results30 May 2024, 8:20PM Fischer Medical Ventures informs about press release27 May 2024, 2:54PM Fischer Chemic informs about outcome of board meeting4 May 2024, 3:07PM Fischer Chemic informs about outcome of board meeting4 May 2024, 3:03PM Fischer Chemic informs about board meeting4 May 2024, 2:52PM Fischer Chemic informs about details of loss of certificate 23 Mar 2024, 11:48AM Fischer Chemic - Quaterly Results12 Feb 2024, 8:59PM Fischer Chemic - Quaterly Results12 Feb 2024, 8:59PM Fischer Chemic gets nod to acquire 100% stake in Time Medical International Ventures16 Dec 2023, 3:45PM Fischer Chemic - Quaterly Results1 Nov 2023, 7:40PM Fischer Chemic - Quaterly Results1 Nov 2023, 7:40PM Fischer Chemic informs about disclosure29 Apr 2023, 11:18AM Fischer Chemic informs about corrigendum to EGM notice 25 Apr 2023, 12:00PM Fischer Chemic informs about resignation of internal auditor28 Jan 2023, 12:01PM Fischer Chemic - Quaterly Results17 Nov 2022, 6:22PM Fischer Chemic - Quaterly Results17 Nov 2022, 6:22PM Fischer Chemic - Quaterly Results10 Aug 2022, 5:05PM Fischer Chemic informs about outcome of independent director meet26 Mar 2022, 3:06PM Fischer Chemic - Quaterly Results9 Feb 2022, 6:26PM Fischer Chemic - Quaterly Results9 Feb 2022, 6:26PM Fischer Chemic informs about trading window closure31 Dec 2021, 2:12PM

Fischer Medical Stock Price Analysis and Quick Research Report. Is Fischer Medical an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Fischer Medical stock price today is Rs 649.95. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Fischer Medical . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Fischer Medical has a PE ratio of 2402.77264325324 which is high and comparatively overvalued .

  • Share Price: - The current share price of Fischer Medical is Rs 649.95. One can use valuation calculators of ticker to know if Fischer Medical share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Fischer Medical has ROA of 0.8746 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Fischer Medical has a Current ratio of 4.1515 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Fischer Medical has a ROE of 1.0257 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Fischer Medical has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Fischer Medical has reported revenue growth of 6322.3955 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Fischer Medical for the current financial year is -1.69323918738398 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Fischer Medical is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Fischer Medical is Rs 0.2705 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Fischer Medical in Ticker for free. Also, one can get the intrinsic value of Fischer Medical by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Fischer Medical
X